# Gevo, Inc. (GEVO)

> Basic Materials · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/GEVO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 89.45M | $ -198.64M | $ -50.78M | $ 170.70M | $ 273.16M |
| 2025 | $ 164.42M | $ -34.65M | $ -44.42M | $ 167.52M | $ 466.34M |
| 2024 | $ 17.78M | $ -82.66M | $ -114.01M | $ 70.62M | $ 489.49M |
| 2023 | $ 18.60M | $ -71.60M | $ -116.96M | $ 70.18M | $ 557.39M |
| 2022 | $ 1.31M | $ -109.48M | $ -143.39M | $ 69.69M | $ 605.48M |
| 2021 | $ 728.6K | $ -70.37M | $ -122.87M | $ 69.89M | $ 547.26M |
| 2020 | $ 6.85M | $ -51.19M | $ -32.16M | $ 1.60M | $ 146.38M |
| 2019 | $ 31.56M | $ -36.99M | $ -34.63M | $ 14.65M | $ 72.50M |
| 2018 | $ 43.37M | $ -36.95M | $ -23.88M | $ 12.95M | $ 88.79M |
| 2017 | $ 37.01M | $ -33.18M | $ -30.35M | $ 14.01M | $ 63.53M |
| 2016 | $ 37.38M | $ -51.22M | $ -36.40M | $ 33.99M | $ 69.26M |
| 2015 | $ 40.46M | $ -50.82M | $ -41.59M | $ 36.69M | $ 48.33M |
| 2014 | $ 39.94M | $ -58.14M | $ -62.01M | $ 39.91M | $ 46.96M |
| 2013 | $ 11.70M | $ -95.01M | $ -80.70M | $ 24.63M | $ 70.98M |
| 2012 | $ 35.21M | $ -87.65M | $ -173.96M | $ 49.51M | $ 97.83M |
| 2011 | $ 94.83M | $ -70.83M | $ -61.16M | $ 28.24M | $ 92.14M |
| 2010 | $ 24.83M | $ -60.74M | $ -32.86M | $ 20.43M | $ 19.96M |
| 2009 | $ 0 | $ -30.11M | $ -28.89M | $ 7.70M | $ 15.08M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.62 |
| Liabilities / Eq | 0.77 |
| Current Ratio | 2.70 |

## Other views

- [Metrics](https://sponda.capital/en/GEVO.md)
- [Charts](https://sponda.capital/en/GEVO/charts.md)
- [Compare](https://sponda.capital/en/GEVO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.